Tuberculosis (TB) management faced challenges caused by the coronavirus pandemic (2020-2021), causing an increase in deaths from this illness worldwide. This study aimed to analyze the impact of COVID-19 on TB morbidity and mortality in Brazil. It is a retrospective, observational, quantitative, documentary-based study with a comparative-statistical approach. The research was based on the Sistema de Informação de Agravos de Notificação (Sinan Net) and Sistema de Informações Hospitalares do Sistema Único de Saúde (SIH/SUS). These results revealed a decrease in the number of notifications of the disease between 2019 to 2021 (10%). However, the mortality rate increased from 7.93% to 11.38%. There was a predominance of the illness among male patients (70.13%), in the age group of 20 to 59 years (77.38%), of brown color/race (49.34%), and with a poor school education (41.38%). Most cases were pulmonary (84.73%), new ones (79.62%), and progressed to cure (53.38%). A smaller number of cases were resistant (.48%), especially first-line drugs. This study shows the increase in Tuberculosis morbimortality with the advent of the pandemic of COVID-19. The patients’ treatment and orientation were compromised by levels of co-infection, the reactivation of TB, and the dysfunction of the plan to prevent Tuberculosis. Consequently, the early detection of cases has contributed to a rise in Tuberculosis morbimortality in the period studied.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2023 PsychTech & Health Journal